A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Recruiting · NCT06797336 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors | Solid Tumor | Recruiting | Phase 1 | 2026-10-07 | NCT06797336 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PAQ Therapeutics, Inc. | 2 |
15 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |
| CHA University Bundang Medical Center | Seongnam | South Korea | 3 |
| Dana Farber/Massachusetts General Hospital, Inc | Boston | United States | 1 |
| New Experimental Therapeutics of San Antonio LLC | San Antonio | United States | 2 |
| NEXT Virginia | Fairfax | United States | 83 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| SCRI Lake Mary | Nashville | United States | 1 |
| Scri Oncology Partners | Nashville | United States | 156 |
| Seoul National University Bundang Hospital | Seoul | South Korea | 11 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Severance Hospital, Yonsei University Health System | Seoul | South Korea | 43 |
| START - South Texas Accelerated Research Therapeutics, LLC | San Antonio | United States | 2 |
| START Los Angeles | Los Angeles | United States | 14 |
| START Midwest | Grand Rapids | United States | 79 |
| START Mountain Region | West Valley City | United States | 46 |